AI Article Synopsis
Article Abstract
In the central nervous system (CNS), microglia are innate immune mononuclear phagocytes (CNS MPs) that can phagocytose infectious particles, apoptotic cells, neurons, and pathological protein aggregates, such as Aβ in Alzheimer's disease (AD). While CD11bCD45 microglia account for the majority of CNS MPs, a small population of CD11bCD45 CNS MPs is also recognized in AD that surround Aβ plaques. These transcriptionally and pathologically unique CD45 cells have unclear origin and undefined phagocytic characteristics. We have comprehensively validated rapid flow cytometric assays of bulk-phase and amyloid β fibril (fAβ) phagocytosis and applied these to study acutely isolated CNS MPs. Using these methods, we provide novel insights into differential abilities of CD11b CD45 and CD45 CNS MPs to phagocytose macroparticles and fAβ under normal, acute, and chronic neuroinflammatory states. CD45 CNS MPs also highly upregulate TREM2, CD11c, and several disease-associated microglia signature genes and have a higher phagocytic capacity for Aβ as compared to CD45 microglia in the 5xFAD mouse model of AD that becomes more apparent with aging. Our data suggest an overall pro-phagocytic and protective role for CD11bCD45 CNS MPs in neurodegeneration, which if promoted, could be beneficial.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840283 | PMC |
| http://dx.doi.org/10.3389/fimmu.2018.00405 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of potential ecological risk for microplastics in freshwater ecosystems.
Chemosphere
December 2024
Environmental Risk Assessment Center, Gyeongnam Branch Institute, Korea Institute of Toxicology (KIT), Jinju 52834, Republic of Korea. Electronic address:
Microplastics (MPs) are one of the most widespread environmental pollutants, but their risk assessment to freshwater ecosystems has not been clearly investigated. Risk assessment has been constrained by the absence of MP concentration in some environment, the diverse types and shapes of MPs, and limitations of polystyrene (PS)-biased toxicity studies. This study examined exposure to MPs in rivers and lakes worldwide, including China (the Three Gorges Dam & Yangtze River (TGD & YR) and the lakes of Wuhan city (WL)), Vietnam (seven lakes of Da Nang city (7UL)), Europe (the Rhine River (RR)), Finland (Kallavesi Lake (KL)), Argentina (nine lakes in the Patagonia region (9LP)), Brazil (Guaiba Lake (GL)), and South Korea (Nakdong River (NR), Han River (HR), and Anyang Stream (AS)), and assessed the risks to aquatic ecosystems based on the toxicity information and morphology of MPs.
View Article and Find Full Text PDFThe Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential.
Cell Mol Neurobiol
December 2024
Immunology Department, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Article Synopsis
- Extracellular vesicles (EVs) are tiny membrane-bound particles released by various cells that may contribute to diseases affecting the central nervous system (CNS).
- The presence of microparticles (MPs) in body fluids like cerebrospinal fluid (CSF) could indicate a person's risk for mental health disorders such as schizophrenia and bipolar disorder, with their biomarker changes helping with diagnosis and disease monitoring.
- Studying the role of MPs in CNS diseases is complex due to difficulties in isolating them and their varied functions, but understanding these aspects could unlock their potential for clinical applications.
Collagen I Microfiber Promotes Brain Capillary Network Formation in Three-Dimensional Blood-Brain Barrier Microphysiological Systems.
Biomedicines
October 2024
Laboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki City 210-9501, Kanagawa, Japan.
Background: The blood-brain barrier (BBB) strictly regulates the penetration of substances into the brain, which, although important for maintaining brain homeostasis, may delay drug development because of the difficulties in predicting pharmacokinetics/pharmacodynamics (PKPD), toxicokinetics/toxicodynamics (TKTD), toxicity, safety, and efficacy in the central nervous system (CNS). Moreover, BBB functional proteins show species differences; therefore, humanized in vitro BBB models are urgently needed to improve the predictability of preclinical studies. Recently, international trends in the 3Rs in animal experiments and the approval of the FDA Modernization Act 2.
View Article and Find Full Text PDFInflammation-Targeted Biomimetic Nano-Decoys via Inhibiting the Infiltration of Immune Cells and Effectively Delivering Glucocorticoids for Enhanced Multiple Sclerosis Treatment.
Adv Healthc Mater
October 2024
Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Excessive infiltration of neutrophil and inflammatory cytokines accumulation as well as the inadequate delivery of drugs to the targeted site are key pathological cascades in multiple sclerosis (MS). Herein, inflammation-targeting biomimetic nano-decoys (TFMN) is developed that inhibit the infiltration of immune cells and effectively deliver glucocorticoids to lesions for enhanced MS treatment. Nano-decoys encapsulated with the glucocorticoid methylprednisolone (MPS) are prepared by coating neutrophil membrane (NM) on nanoparticles formed by the self-assembly of tannic acid and poloxamer188/pluronic68.
View Article and Find Full Text PDFEngineering memory T cells as a platform for long-term enzyme replacement therapy in lysosomal storage disorders.
Mol Ther
November 2024
Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address:
Enzymopathy disorders are the result of missing or defective enzymes. Among these enzymopathies, mucopolysaccharidosis type I is a rare genetic lysosomal storage disorder caused by mutations in the gene encoding alpha-L-iduronidase (IDUA), which ultimately causes toxic buildup of glycosaminoglycans (GAGs). There is currently no cure and standard treatments provide insufficient relief to the skeletal structure and central nervous system (CNS).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!